RX CROSSROADS 3PL LLC — Mitomycin Importer Profile
Pharmaceutical Importer · #1 buyer for Mitomycin · $994.3K import value · 21 shipments · UNITED STATES · DGFT Verified
RX CROSSROADS 3PL LLC is the #1 importer of Mitomycin from India with $994.3K in import value and 21 verified shipments. RX CROSSROADS 3PL LLC holds a 12.9% market share in Mitomycin imports based in UNITED STATES. The company sources from 1 verified supplier across 18 formulations shipped to 1 country. Overall, RX CROSSROADS 3PL LLC imports 5 pharmaceutical products worth $7.5M across 4 therapeutic categories.
RX CROSSROADS 3PL LLC — Mitomycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Mitomycin to RX CROSSROADS 3PL LLC?
Verified from 21 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $994.3K | 21 | 100.0% |
RX CROSSROADS 3PL LLC sources Mitomycin from 1 verified Indian supplier based on 21 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
How Does RX CROSSROADS 3PL LLC Compare to Nearest Mitomycin Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | RX CROSSROADS 3PL LLC ★ | UNITED STATES | $1.1M | 21 | $50.0K |
| 5 | EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $290.9K | 15 | $19.4K |
| 6 | EUGIA US LLC | UNITED STATES | $242.5K | 5 | $48.5K |
RX CROSSROADS 3PL LLC ranks #1 among 456 Mitomycin importers from India. Average shipment value of $50.0K compared to the market average of $7.3K. The closest competitors by value are EVERSANA LIFE SCIENCES SERVICES,LLC and EUGIA US LLC.
Where Does RX CROSSROADS 3PL LLC Import Mitomycin To?
Destination countries from 21 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $994.3K | 21 | 100.0% |
RX CROSSROADS 3PL LLC imports Mitomycin to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $994.3K.
What Mitomycin Formulations Does RX CROSSROADS 3PL LLC Import?
| Formulation | Value | Shipments |
|---|---|---|
| Mitomycin FOI 40mg/vial-1s-Mylan-US BATC | $200.0K | 4 |
| Mitomycin FOI 5mg/vial-1s-Mylan-US BATCH | $50.0K | 1 |
| Mitomycin FOI 40mg-1s-US-Archis Pharma Batch No-7802362 | $50.0K | 1 |
| Mitomycin FOI 40mg-1s-US-Archis Pharma Batch No-7802368 | $50.0K | 1 |
| Mitomycin FOI 40mg-1s-US-Archis Pharma Batch No-7802372 | $50.0K | 1 |
| Mitomycin FOI 40mg-1s-US-Archis Pharma (Batch No 7802508) | $50.0K | 1 |
| Mitomycin FOI 40mg-1s-US-Archis Pharma (Batch No 7802516) | $50.0K | 1 |
| Mitomycin FOI 40mg-1s-US-Archis Pharma (Batch No 7802520) | $50.0K | 1 |
| MITOMYCIN FOI 40MG 1S US ARCHIS PHARMA (7802445) TAX VAL 5627123.39 | $50.0K | 1 |
| MITOMYCIN FOI 40MG 1S US ARCHIS PHARMA (7802446) TAX VAL 7870924.16 | $50.0K | 1 |
RX CROSSROADS 3PL LLC imports 18 distinct Mitomycin formulations from India. The top formulation is Mitomycin FOI 40mg/vial-1s-Mylan-US BATC with 4 shipments worth $200.0K.
Regulatory Requirements: Importing Mitomycin into United States
What RX CROSSROADS 3PL LLC and other importers must comply with to import Mitomycin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Mitomycin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Mitomycin from India and How Much Does RX CROSSROADS 3PL LLC Import?
India exported $3.3M worth of Mitomycin through 1,333 shipments from 213 suppliers to 103 countries, serving 456 buyers globally. RX CROSSROADS 3PL LLC imports $994.3K of this total, accounting for 12.9% of India's Mitomycin exports with 21 shipments from UNITED STATES. This is verified from 21 customs shipment records covering 18 distinct formulations.
What Is the Average Order Value for RX CROSSROADS 3PL LLC's Mitomycin Imports?
RX CROSSROADS 3PL LLC's average Mitomycin order value is $47.3K per consignment, based on 21 shipments totaling $994.3K. RX CROSSROADS 3PL LLC is based in UNITED STATES and ranks #1 among all Mitomycin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Mitomycin to RX CROSSROADS 3PL LLC?
RX CROSSROADS 3PL LLC sources Mitomycin from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($994.3K, 100.0%). This is based on 21 customs records.
How Does RX CROSSROADS 3PL LLC Compare to Other Mitomycin Importers?
RX CROSSROADS 3PL LLC ranks #1 among 456 Mitomycin importers from India with a 12.9% market share. The top 3 importers are RX CROSSROADS 3PL LLC ($1.1M), EVERSANA LIFE SCIENCES SERVICES,LLC ($290.9K), EUGIA US LLC ($242.5K). RX CROSSROADS 3PL LLC processed 21 shipments from UNITED STATES.
About RX CROSSROADS 3PL LLC
RX CROSSROADS 3PL LLC imports 5 products worth $7.5M. Beyond Mitomycin, top products include Dexamethasone, Tobramycin, Sulfamethoxazole, Trimethoprim. View the complete RX CROSSROADS 3PL LLC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mitomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Mitomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: RX CROSSROADS 3PL LLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as RX CROSSROADS 3PL LLC's capped import value divided by total capped export value for Mitomycin across all Indian exporters.
- 5.Verified Records: This page is backed by 21 individual customs records matching RX CROSSROADS 3PL LLC importing Mitomycin, covering 18 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 103+ countries, 456+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Mitomycin Import Data for RX CROSSROADS 3PL LLC
Access order-level details, pricing data, supplier connections, and competitive analysis for RX CROSSROADS 3PL LLC's Mitomycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
RX CROSSROADS 3PL LLC
Full Company Profile →
5 products · $7.5M total trade · 4 categories
RX CROSSROADS 3PL LLC × Mitomycin
Verified from customs records
Company Overview
Top Products by RX CROSSROADS 3PL LLC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for RX CROSSROADS 3PL LLC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mitomycin. For current order-level data, contact TransData Nexus.